FDA
-
-
-
-
-
-
-
TLC (TLC) Submits IND Application for TLC19 Inhalable Liposomal Hydroxychloroquine for COVID-19
-
-
-
-
-
-
-
TLC Reports Second Quarter 2019 Financial Results and Provides Business Update
-
-
-
-
329,074 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

